Biocon profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 1.4% | 1.4% | 4.9% | 5.4% | 3.5% | ||
| 0.6% | 0.6% | 2.5% | 2.4% | 0.5% | ||
| 3.2% | 3.2% | 3.5% | 4.1% | 1.3% | ||
| 2.7% | 2.6% | 2.7% | 3.8% | 2.8% | ||
Margins | ||||||
| 20.4% | 20.4% | 20.8% | 22.4% | 22.5% | ||
| 8.9% | 8.9% | 9.7% | 11.7% | 12.5% | ||
| — | 1.2% | −49.5% | 9.3% | — | ||
| 2.8% | 2.6% | 12.4% | 10.9% | 9.5% | ||
| 2.4% | 2.2% | 9.4% | 8.8% | 5.8% | ||
| 2.9% | 2.3% | 6.6% | 6.9% | 4.1% | ||
| 0.5% | 0.5% | 11.3% | 6.9% | 1.1% | ||
Additional | ||||||
| 13.0% | 17.7% | 24.2% | 14.1% | 23.9% | ||
| — | 24.6% | 5.8% | 15.6% | 11.2% | ||
| 1.4% | 1.0% | 4.6% | 4.6% | 3.1% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.